Celldex Therapeutics | CLDX - EPS Earnings Per Share

Stock Price
24.27
Daily Change
-0.90 -3.58%
Monthly
-5.20%
Yearly
1.17%
Q1 Forecast
23.84

Celldex Therapeutics reported $-1.01 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1 -0.71 Mar/02 2026
FY2025Q3 Sep/2025 -1.01 -0.9 -0.64 Nov/10 2025
FY2025Q2 Jun/2025 -0.85 -0.80 -0.54 Aug/07 2025
FY2025Q1 Mar/2025 -0.71 -0.76 -0.56 May/05 2025
FY2024Q4 Dec/2024 -0.71 -0.69 -0.83 Feb/27 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Celldex Therapeutics USD -1.01 0.16 Sep/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025